China NMPA Inspection - Nanyang Aofulai Industrial Co., Ltd. - September 02, 2019

This document constitutes an official announcement from the National Medical Products Administration (NMPA) concerning an unannounced regulatory inspection conducted on Nanyang Aofulai Industrial Co., Ltd. The notification was formally published on September 2, 2019. While it explicitly identifies the company subjected to the inspection, Nanyang Aofulai Industrial Co., Ltd., and establishes the regulatory body, the NMPA, as the authority performing this oversight, the provided content is restricted to this introductory information. The document does not furnish details pertaining to the specific dates on which this inspection took place, nor does it enumerate any main violations, significant issues, or non-conformities that may have been discovered during the assessment. Consequently, information regarding the particular regulatory framework or specific chapters of regulations under which the inspection was carried out is not articulated. Furthermore, the notification does not outline any required actions, corrective measures, or remedial plans that Nanyang Aofulai Industrial Co., Ltd. might be obligated to implement following the inspection. Its scope is limited to announcing the inspection event.